Evidence map›Paper›PMID 30541895›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.

Guo Luo, Aditya Ambati, Ling Lin, Mélodie Bonvalet, Markku Partinen, Xuhuai Ji, Holden Terry Maecker, Emmanuel Jean-Marie Mignot

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Narcolepsy is (not) an autoimmune disease.Nature reviews. Neurology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. HLA-DQB1*03:01 strongly affects age of onset of type 1 narcolepsy independently of DQA1 and ethnicity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. The immunopathogenesis of narcolepsy type 1.Nature reviews. Immunology · 2024
    Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Guo LuoCenter for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.
Aditya AmbatiCenter for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.
Ling LinCenter for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.
Mélodie BonvaletCenter for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.
Markku PartinenHelsinki Sleep Clinic, Vitalmed Research Centre, 00380 Helsinki, Finland.
Xuhuai JiImmune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.
Holden Terry MaeckerImmune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.
Emmanuel Jean-Marie MignotCenter for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304; mignot@stanford.edu.
Stanford University · USUniversity of Helsinki · FI

Funding

SPECTRUM OF NARCOLEPSY AND ITS SYMPTOMSP50NS023724 · NINDS · STANFORD UNIVERSITY · PI MIGNOT, EMMANUEL J · 1986 to 2016
$18.9M
High-throughput sequencer for multi-scale genomic studiesS10OD020141 · OD · STANFORD UNIVERSITY · PI SNYDER, MICHAEL P. · 2015 to 2015
$600k
NIAID NIH HHS HHSN272201300006CNIH HHS S10 OD020141NINDS NIH HHS P50 NS023724
6 · The paper itself

Abstract

Type 1 narcolepsy (T1N) is caused by hypocretin/orexin (HCRT) neuronal loss. Association with the HLA DQB1*06:02/DQA1*01:02 (98% vs. 25%) heterodimer (DQ0602), T cell receptors (TCR) and other immune loci suggest autoimmunity but autoantigens are unknown. Onset is seasonal and associated with influenza A, notably pandemic 2009 H1N1 (pH1N1) infection and vaccination (Pandemrix). Peptides derived from HCRT and influenza A, including pH1N1, were screened for DQ0602 binding and presence of cognate DQ0602 tetramer-peptide-specific CD4

Indexed as

AdolescentAdultAutoantigensAutoimmunityCD4-Positive T-LymphocytesChildEpitopesFemaleHemagglutininsHLA-DQ beta-ChainsHumansInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza, HumanIntracellular Signaling Peptides and ProteinsMaleAutoantigensEpitopesHCRT protein, humanHemagglutininsHLA-DQB1 antigenHLA-DQ beta-ChainsIntracellular Signaling Peptides and ProteinsOrexinsPeptidesReceptors, Antigen, T-CellautoimmunityDQ0602narcolepsyTCRtetramer

Identifiers

PMID30541895
PMCPMC6310865
OpenAlexW2904549325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.